• Profile
Close

Independent effects of secondary hyperparathyroidism and hyperphosphatemia on chronic kidney disease progression and cardiovascular events: An analysis from the NEFRONA cohort

Nephrology Dialysis Transplantation May 28, 2021

Bozic M, Diaz-Tocados JM, Bermudez-Lopez M, et al. - This study was attempted to investigate the possible independent effects of secondary hyperparathyroidism (SHPT) (defined as patients with excessive PTH levels or on treatment with PTH decreasing agents) on the risk of chronic kidney disease (CKD) progression and cardiovascular events (CVE) incidence in CKD patients, as well as if hypercalcemia and/or hyperphosphatemia act as effect modifiers. Researchers recruited a total of 2,445 CKD patients without previous CVE from the NEFRONA cohort (950 stage 3, 612 stage 4, 195 stage 5, and 688 on Dialysis). The risk of patients suffering CKD progression or a CVE was ascertained by using Multivariate logistic and Fine and Gray regression analysis. It was shown that in CKD patients, SHPT and hyperphosphatemia are independently correlated with CKD progression and the incidence of CVE.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay